DFSG 2025
Sponsors and exhibition
Interested in sponsoring DFSG 2025?
Get contacted by our dedicated sponsorship and
exhibition team to explore your opportunities.
Thank you to our confirmed sponsors
Join us as a sponsor or exhibitor at DFSG 2025 and connect with leading experts dedicated to advancing diabetic foot care. This is your opportunity to engage with a highly specialised audience, showcase your latest solutions, and contribute to discussions in an inspiring environment.
For more details, download the sponsorship prospectus or contact our sponsorship & exhibition manager directly.
Gold sponsors
Pioneering trusted medical solutions to improve the lives we touch.
Convatec is an innovative global medical products and technologies company, focused on solutions for the management of chronic conditions.
We have leading positions in Advanced Wound Care, Ostomy Care, Continence Care and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by our promise to be forever caring.
Our solutions provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total costs of care.
Bronze sponsors
Essity is a leading global hygiene and health company aiming to break barriers to well-being.
With world-renowned brands such as the registered trademarks Leukoplast, Cutimed and JOBST,
Essity is among the global market leaders within its Medical Solutions categories wound care and compression.
At Urgo Medical, our mission is to support Healthcare Professionals to deliver evidence-based advanced wound care treatments from the beginning so that life can start again for patients. Our 1.600 employees are committed every day to making a difference for patients.
Exhibitors
GCRI is a full-service CRO specialised in Wound Care and Diabetic Foot research.
Tarsos is a MedTech company focused on improving diabetic foot care through innovative, data-driven solutions.
Combining expertise in biomedical engineering, sensor technology, and digital health, Tarsos is supporting clinicians with Senstep, a cutting-edge in-shoe monitoring system designed to aid the early detection and prevention of diabetic foot complications.
Senstep continuously tracks plantar temperature distribution, a clinically validated marker for inflammation and potential ulcer development. Its seamless integration with a mobile app provides clinicians with real-time, actionable data to support clinical decision-making and timely intervention.
The system delivers objective insights that complement visual inspection and standard care, enabling more personalised and proactive management of at-risk patients.
By identifying early signs of complications, Senstep empowers healthcare professionals to reduce ulcer incidence, prevent avoidable amputations, and ultimately improve patient outcomes.
